课题基金 / 基金详情

A new strategy for antibody-therapy against infectious diseases and bacterial terrorism using lymphocyte-chip

A new strategy for antibody-therapy against infectious diseases and bacterial terrorism using lymphocyte-chip
利用淋巴细胞芯片针对传染病和细菌恐怖主义进行抗体治疗的新策略
批准号:
20390286
负责人:
MURAGUCHI Atsushi
金额:
$12.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

MURAGUCHI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
我们建立了一种利用小鼠系统检测微孔中抗体分泌细胞的方法ISAAC (Immunospot assay for antibody-secreting cell)。随后,我们利用ISAAC方法在很短的时间内成功地从接种疫苗的健康志愿者中获得了高质量的乙型肝炎病毒和流感病毒单克隆抗体;一周之内。我们进一步建立了一套体外检测系统,检测人抗HBs抗体的hbv中和活性,并阐明了人单克隆抗体的中和活性与HBs抗原表位的关系。
英文摘要
We developed ISAAC (Immunospot assay for antibody-secreting cell) method that can detect antibody-secreting cells in a microwell using murine system. We then succeeded in generating high-quality human monoclonal antibodies for hepatitis B virus and influenza virus from vaccinated healthy volunteers using the ISAAC method in a very short time ; within one week. We further developed an in vitro assay system to examine the HBV-neutralizing activity of human anti-HBs antibodies and clarified the relationship between neutralizing activity of human mAbs and epitopes of HBs antigen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement of TRAIL-induced apoptosis with novel TRAIL-R1-specific human mAbs generated by immunospot array assay on a chip.
通过芯片上的免疫点阵列测定产生的新型 TRAIL-R1 特异性人单克隆抗体增强 TRAIL 诱导的细胞凋亡。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Kishi H, Jin A, Ozawa T, Tajiri K, Lin Z, Obata T, Ishida I, Muraguchi A.]
通讯作者: Muraguchi A.
Detection of antigen-specific T-cell response on the single cell-basis with microwell array chip.
使用微孔阵列芯片在单细胞基础上检测抗原特异性 T 细胞反应。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Kishi H, Tajiri K, Hatakeyama S, Kobayashi E, Horii M, Jin A, Ozawa T, Muraguchi A.]
通讯作者: Muraguchi A.
Rapid and efficient cloning and functional evaluation system for antigen-specific T cell receptor obtained from single T-cells.
从单个 T 细胞获得的抗原特异性 T 细胞受体的快速高效克隆和功能评估系统。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Horii M, Kobayashi E, Hatakeyama S, Ozawa T, Tajiri K, Kishi H, Muraguchi A.]
通讯作者: Muraguchi A.
DOI: 10.1038/nm.1966
发表时间: 2009-09-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者: [Jin, Aishun, Ozawa, Tatsuhiko, Muraguchi, Atsushi]
通讯作者: Muraguchi, Atsushi
55
    Development of an innovative lymphocyte chip to establish personalized immuno-therapy for infectious diseases
    • 批准号:
      26293237
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2014
    • 负责人:
      MURAGUCHI Atsushi
    • 依托单位:
    Challenge the infectious diseases and cancers using innovative array technology: Development of hTEC10
    • 批准号:
      25670463
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MURAGUCHI Atsushi
    • 依托单位:
    Establishment of personalized immunotherapy method for virus-infected diseases using lymphocyte chip
    • 批准号:
      23390264
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      MURAGUCHI Atsushi
    • 依托单位:
    Development of rapid production of human monoclonal antibodies against emerging infectious pathogens using lymphocyte chip
    • 批准号:
      18390288
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.88万
    • 财政年份:
      2006
    • 负责人:
      MURAGUCHI Atsushi
    • 依托单位:
    海外基金